SHP2-silenced tumor cells produced reduced levels of a heterogeneous set of vascular regulators, cytokines, and chemokines compared with the control, and tumors derived from these SHP2-silenced cells were less vascularized, the vessels were remodeled, and proinflammatory cells were fewer. The gene discussed is PTPN11; the disease is neoplasm.